Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.11
1.94 %
$ 767 M
Market Cap
-13.31
P/E
INCOME STATEMENT
202 M
REVENUE
-49.2 M
OPERATING INCOME
-61.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Evolus, Inc.
| Revenue | 202 M |
| Cost Of Revenue | 61.6 M |
| Gross Profit | 141 M |
| Operating Expenses | 190 M |
| Operating Income | -49.2 M |
| Other Expenses | 12.5 M |
| Net Income | -61.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 202.1 | 148.6 | 99.7 | 56.5 | 34.9 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 61.6 | 55.9 | 43.5 | 18.3 | 8.0 | 9 K | 0.2 | 0.3 | 0.4 |
| Gross Profit | 140.5 | 92.7 | 56.1 | 38.2 | 26.9 | 9 K | (0.2) | (0.3) | (0.4) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 189.8 | 150.3 | 119.8 | 106.9 | 121.7 | 35.6 | 11.7 | 20.0 | 31.0 |
| Selling, General and Administrative Expenses | 164.9 | 141.8 | 112.1 | 98.2 | 113.6 | 29.1 | 4.8 | 7.0 | 9.9 |
| Research and Development Expenses | 6.6 | 4.7 | 2.1 | 1.7 | 4.0 | 6.5 | 6.7 | 12.6 | 20.7 |
| Operating Income | (49.2) | (57.6) | (63.6) | (68.7) | (94.8) | (46.1) | (11.7) | (20.0) | (31.0) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 13.8 | 9.1 | 1.4 | 10.5 | 8.0 | 0.9 | 0 | 0 | 0 |
| Total Other Income | (12.3) | (9.0) | (2.4) | (9.9) | (6.1) | (0.7) | 5 K | 6 K | 39 K |
| Pre-Tax Income | (61.5) | (74.3) | (46.8) | (162.9) | (105.1) | (46.8) | (11.7) | (20.0) | (31.0) |
| NET INCOME | |||||||||
| Tax Provision | 0.2 | 95 K | 42 K | 77 K | (15.0) | 65 K | (7.3) | 93 K | 93 K |
| Net Income | (61.7) | (74.4) | (46.8) | (163.0) | (90.0) | (46.9) | (4.5) | (20.1) | (31.1) |
| EPS | 1.08 | 1.33 | 0.94 | 4.83 | 3.19 | 1.92 | 0.19 | 1.08 | 1.67 |